UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 10, 2010 (March 10, 2010)
____________
DIALYSIS CORPORATION OF AMERICA
(Exact name of registrant as specified in its charter)
Florida 0-8527 59-1757642
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1302 Concourse Drive, Suite 204, Linthicum, MD 21090
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (410) 694-0500
____________
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition
On March 10, 2010, Dialysis Corporation of America issued a press
release announcing its financial results for the year ended December 31,
2009. A copy of the March 10, 2010 press release is attached as an exhibit
to this Current Report, and is incorporated herein by reference.
The information furnished pursuant to this Item 2.02, including the
Exhibit (99)(i), shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933.
As previously announced in its press release on February 26, 2010,
Dialysis Corporation of America will be hosting a conference call in
conjunction with the press release of its financial results attached as the
exhibit to this current report. The conference call will be held on
Thursday, March 11, 2010 at 10:00 a.m. EST. The call is accessible either by
dialing (866) 238-0826 (enter attendee passcode 1437866), or by audio
simulcast on the internet through the company's website at
http://www.dialysiscorporation.com/companyinfo/investorrelations.htm. A copy
of this current report on Form 8-K and the attached press release announcing
the financial results for fiscal 2009 will be available through the company's
website, www.dialysiscorporation.com, under the "Investor Relations - SEC
Filings" tabs. An audio replay of the conference call will be available on
the company's website for a period of thirty days following the conference
call.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
(99) Additional Exhibits
(i) Press Release dated March 10, 2010
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DIALYSIS CORPORATION OF AMERICA
/s/ Stephen W. Everett
By______________________________
STEPHEN W. EVERETT
President and Chief Executive Officer
Dated: March 10, 2010
EXHIBIT INDEX
Exhibit No.
- ----------
(99)(i) Press Release dated March 10, 2010
JAFFE LAW, LLC
777 Terrace Avenue
Hasbrouck Heights, NJ 07604
Telephone: (201)288-8282
Facsimile: (201) 288-8208
Email: jmj@lawjaffe.com
March 10, 2010
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE: Dialysis Corporation of America Current Report on Form 8-K
Commission File No. 0-8527
Gentlemen:
Enclosed is the aforementioned company's Current Report on Form 8-K and
exhibit pursuant to the requirements of the Securities Exchange Act of 1934,
which is being furnished pursuant to the Commission's EDGAR system.
Very truly yours,
JAFFE LAW, LLC
/s/Joshua M. Jaffe
By: _____________________________
Joshua M. Jaffe
JMJ:naf
Enclosure
cc: Nasdaq Stock Market, Inc.